See also Phosphodiesterase type III inhibitors

General information

Pimobendan is an inhibitor of phosphodiesterase type III with calcium-sensitizing properties in the myocardium. It has been associated with a worrisome albeit non-significant increase in mortality in patients with chronic congestive heart failure [ ].

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here